1. Home
  2. LAR vs MRVI Comparison

LAR vs MRVI Comparison

Compare LAR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAR
  • MRVI
  • Stock Information
  • Founded
  • LAR 2007
  • MRVI 2014
  • Country
  • LAR Switzerland
  • MRVI United States
  • Employees
  • LAR N/A
  • MRVI N/A
  • Industry
  • LAR
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LAR
  • MRVI Health Care
  • Exchange
  • LAR NYSE
  • MRVI Nasdaq
  • Market Cap
  • LAR 335.1M
  • MRVI 312.4M
  • IPO Year
  • LAR N/A
  • MRVI 2020
  • Fundamental
  • Price
  • LAR $2.33
  • MRVI $2.67
  • Analyst Decision
  • LAR Buy
  • MRVI Hold
  • Analyst Count
  • LAR 1
  • MRVI 10
  • Target Price
  • LAR $3.00
  • MRVI $6.84
  • AVG Volume (30 Days)
  • LAR 1.0M
  • MRVI 1.9M
  • Earning Date
  • LAR 08-12-2025
  • MRVI 08-06-2025
  • Dividend Yield
  • LAR N/A
  • MRVI N/A
  • EPS Growth
  • LAR N/A
  • MRVI N/A
  • EPS
  • LAR N/A
  • MRVI N/A
  • Revenue
  • LAR N/A
  • MRVI $241,856,000.00
  • Revenue This Year
  • LAR N/A
  • MRVI N/A
  • Revenue Next Year
  • LAR N/A
  • MRVI $10.62
  • P/E Ratio
  • LAR N/A
  • MRVI N/A
  • Revenue Growth
  • LAR N/A
  • MRVI N/A
  • 52 Week Low
  • LAR $1.71
  • MRVI $1.67
  • 52 Week High
  • LAR $3.96
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • LAR N/A
  • MRVI 67.02
  • Support Level
  • LAR N/A
  • MRVI $2.32
  • Resistance Level
  • LAR N/A
  • MRVI $2.72
  • Average True Range (ATR)
  • LAR 0.00
  • MRVI 0.15
  • MACD
  • LAR 0.00
  • MRVI 0.05
  • Stochastic Oscillator
  • LAR 0.00
  • MRVI 92.36

About LAR LITHIUM ARGENTINA AG

Lithium Argentina is a pure-play lithium producer. The company owns two neighboring lithium brine resources in northwest Argentina: Cauchari-Olaroz and Pastos Grandes. Cauchari-Olaroz entered production in 2023, while Pastos Grandes is still in development. Lithium Argentina plans for both resources to be fully integrated with onside downstream processing capabilities and will sell into the lithium chemical market.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: